Atlas Trials

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

Clinical trial NCT04076449 · RECRUITING

Trial details

NCT number
NCT04076449
Sponsor
yuanli Zhao
Status
RECRUITING
Study type
OBSERVATIONAL
Cavernous Malformation, CerebralCavernous AngiomaCavernous HemangiomaCavernous Hemangioma of BrainSeizuresSeizures, EpilepticEpilepsy
Start date
2019-09-03
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.